IMGN853-0401

First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of IMGN853 in Adults With Ovarian Cancer and Other FOLR1-Positive Solid Tumors


Fox Chase Cancer Center - Philadelphia
7604 Central Avenue Lower Level
Friends Hall Physicians Building
Philadelphia, PA 19111
215-214-1472

Massachusetts General Hospital Cancer Center
55 Fruit Street
Boston, MA 02114

Ohio State University Medical Center
410 West Tenth Avenue
Columbus, OH 43210

Harper University Hospital - DMC
3990 John R
Detroit, MI 48201
313-576-8096

Sarah Cannon Cancer Center
250 25th Avenue North, Suite 110
Nashville, TN 37203

University of Kansas Medical Center Research Institute
Fairway, KS 66205
913-588-4769

University of Oklahoma Health Sciences Center
1200 Children's Ave. Suite 10000
Oklahoma City, OK 73104
405-271-8707

University of Texas Health Science Center
7703 Floyd Curl Drive
San Antonio, TX 78229
210-450-1804